Provided by Tiger Trade Technology Pte. Ltd.

GlucoTrack, Inc.

4.25
+0.02000.47%
Pre-market: 4.320.0701+1.65%07:23 EDT
Volume:153.72K
Turnover:640.61K
Market Cap:3.00M
PE:-0.04
High:4.36
Open:4.20
Low:4.00
Close:4.23
52wk High:212.10
52wk Low:3.75
Shares:705.25K
Float Shares:701.36K
Volume Ratio:0.13
T/O Rate:21.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-112.7747
EPS(LYR):-468.2383
ROE:-620.63%
ROA:-164.45%
PB:-1.72
PE(LYR):-0.01

Loading ...

GlucoTrack Announces Special Shareholder Meeting

Reuters
·
Aug 01

GlucoTrack announces expansion of ai Futures Lab

TIPRANKS
·
Jul 31

GlucoTrack Unit Lokahi Therapeutics Expands Ai2 Futures Lab to 12 University Partnerships

Reuters
·
Jul 31

NASDAQ Trade Halt Volatility Trading Pause at 03:18 Pm

Reuters
·
Jul 31

Top Premarket Gainers

MT Newswires Live
·
Jul 30

GlucoTrack Unit Lokahi Therapeutics Targets Single-shot Lt-100 Dosing in Planned Q4 2026 Trial

Reuters
·
Jul 30

GlucoTrack Amends 8-K to Update Terms of $900,000 Note-for-shares Exchange Agreement

Reuters
·
Jul 30

Lokahi Therapeutics: Anticipates Clinical Evaluation of Single-Injection Lt-100 as Early as Q4 2026

THOMSON REUTERS
·
Jul 30

LŌKahi Therapeutics™ Advances Lt-100 Development Strategy Toward Single-Injection Administration

THOMSON REUTERS
·
Jul 30

GlucoTrack Enters Exchange Deal on $900,000 Promissory Note with Investor

Reuters
·
Jul 28

E.f. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

THOMSON REUTERS
·
Jul 18

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.f. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

THOMSON REUTERS
·
Jul 17

GlucoTrack (GCTK) Stock Rallies 16% After Hours: Here's What Is Going On

Benzinga
·
Jul 17

Update – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-controlled Public Platform

THOMSON REUTERS
·
Jul 17

Press Release: Update

Dow Jones
·
Jul 17

Glucotrack - Lokahi Therapeutics Becomes Wholly Owned Subsidiary of Glucotrack - SEC Filing

THOMSON REUTERS
·
Jul 16

Glucotrack - Lokahi Shareholders to Receive 19.99% of Glucotrack Common Stock Outstanding as of Merger Date - SEC Filing

THOMSON REUTERS
·
Jul 16

Glucotrack - Enters Merger Agreement with Lokahi Therapeutics on July 14, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 16

Top Premarket Gainers

MT Newswires Live
·
Jul 15

GlucoTrack, Lokahi Therapeutics Complete Merger

MT Newswires Live
·
Jul 15